Mefruside

Mefruside

Clinical data
AHFS/Drugs.com	International Drug Names
Routes of administration	Oral
ATC code	C03BA05 ( WHO )
Legal status
Legal status	In general: ℞ (Prescription only)
Identifiers
IUPAC name 4-chloro-N1-methyl-N1-[(2-methyltetrahydrofuran-2-yl)methyl]benzene-1,3-disulfonamide
CAS Number	7195-27-9  Y
PubChem CID	4047
ChemSpider	3907  N
UNII	X1NS9SNS92
KEGG	D01877  Y
CompTox Dashboard (EPA)	DTXSID0048844
ECHA InfoCard	100.027.785
Chemical and physical data
Formula	C13H19ClN2O5S2
Molar mass	382.87 g·mol−1
3D model (JSmol)	Interactive image
SMILES CC1(CCCO1)CN(C)S(=O)(=O)C2=CC(=C(C=C2)Cl)S(=O)(=O)N
InChI InChI=1S/C13H19ClN2O5S2/c1-13(6-3-7-21-13)9-16(2)23(19,20)10-4-5-11(14)12(8-10)22(15,17)18/h4-5,8H,3,6-7,9H2,1-2H3,(H2,15,17,18) N Key:SMNOERSLNYGGOU-UHFFFAOYSA-N N
NY  (what is this?)    (verify)

Mefruside (INN) is a diuretic indicated for the treatment of edema and hypertension. ^[1]

It was developed by Bayer A.G. and is sold under the tradename Baycaron.

References

1. Allen HB, Lee DA (1973). "A general practice assessment of mefruside ('Baycaron') in the treatment of oedema and hypertension". Curr Med Res Opin. 1 (9): 547–53. doi:10.1185/03007997309111720. PMID   4779251.